KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Current Assets (2017 - 2025)

Historic Current Assets for Moderna (MRNA) over the last 9 years, with Q3 2025 value amounting to $6.6 billion.

  • Moderna's Current Assets fell 3174.01% to $6.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.6 billion, marking a year-over-year decrease of 3174.01%. This contributed to the annual value of $8.1 billion for FY2024, which is 2155.93% down from last year.
  • According to the latest figures from Q3 2025, Moderna's Current Assets is $6.6 billion, which was down 3174.01% from $6.2 billion recorded in Q2 2025.
  • In the past 5 years, Moderna's Current Assets ranged from a high of $16.4 billion in Q1 2022 and a low of $6.2 billion during Q2 2025
  • Moreover, its 5-year median value for Current Assets was $10.8 billion (2023), whereas its average is $11.1 billion.
  • In the last 5 years, Moderna's Current Assets soared by 83628.79% in 2021 and then tumbled by 3612.46% in 2025.
  • Moderna's Current Assets (Quarter) stood at $16.1 billion in 2021, then decreased by 16.43% to $13.4 billion in 2022, then fell by 23.13% to $10.3 billion in 2023, then decreased by 21.56% to $8.1 billion in 2024, then dropped by 18.53% to $6.6 billion in 2025.
  • Its last three reported values are $6.6 billion in Q3 2025, $6.2 billion for Q2 2025, and $6.8 billion during Q1 2025.